Clinical evaluation of dried blood spots for the determination of tamoxifen and endoxifen levels

• Conditions: breast cancer; mammacarcinoma; 10006291

• Registration Number: NL-OMON37023
• Lead Sponsor: Slotervaartziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

- Treated with tamoxifen
- Age 18 years or older
- Able and willing to give informed consent
- Able and willing to undergo a fingerprick for dried blood spot sampling

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Ratio of the concentration tamoxifen and endoxifen in serumsamples and<br /><br>concentration of tamoxifen and endoxifen in dried blood spot samples.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>